Does COVID-19 Cause Non-Dıpper Hypertension?

Adverse effects associated with favipiravir in patients with COVID-19 pneumonia: a retrospective study

(2022) Figen Öztürk Ergür et al.   Sao Paulo Medical Journal

Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients

(2022) Virginie Montiel et al.   EBioMedicine

The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies

(2022) Dang The Hung et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection

(2021) Stephany Beyerstedt et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

(2021) Chaolin Huang et al.   LANCET

Arterial stiffness in acute COVID‐19 and potential associations with clinical outcome

(2021) Sebastian Schnaubelt et al.   JOURNAL OF INTERNAL MEDICINE

Hypertension, a Moving Target in COVID-19

(2021) Carmine Savoia et al.   CIRCULATION RESEARCH

Carotid stiffness, intima–media thickness and aortic augmentation index among adults with SARS‐CoV‐2

(2021) Rachel E. Szeghy et al.   EXPERIMENTAL PHYSIOLOGY

Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study

(2021) Aris T. Papageorghiou et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Evidence For and Against Direct Kidney Infection by SARS-CoV-2 in Patients with COVID-19

(2021) Luise Hassler et al.   Clinical Journal of the American Society of Nephrology

Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine

(2021) Martina Zappa et al.   European Journal of Internal Medicine

Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination

(2021) Sylvain Meylan et al.   HYPERTENSION

SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients

(2021) Lucía Gutiérrez-Chamorro et al.   Viruses-Basel

Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database

(2021) Rimple Kaur et al.   International Journal of General Medicine

Does COVID-19 Cause Hypertension?

(2021) Mahmut Akpek   ANGIOLOGY

Kidney injury in COVID-19 patients, drug development and their renal complications: Review study

(2021) Zeynab Mohamadi Yarijani et al.   BIOMEDICINE & PHARMACOTHERAPY

Short term blood pressure alterations in recently COVID-19 vaccinated patients

(2021) Elias Sanidas et al.   European Journal of Internal Medicine

Mechanisms of SARS-CoV-2 entry into cells

(2021) Cody B. Jackson et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Evaluation of the cardio-ankle vascular index in COVID-19 patients

(2021) Ercan Aydın et al.   Revista da Associacao Medica Brasileira

Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies

(2021) Yahya Mahamat-Saleh et al.   BMJ Open

Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study

(2021) Jiang-Shan Tan et al.   Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

(2020) Yingxia Liu et al.   Science China-Life Sciences

Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System

(2020) Mahmoud Gheblawi et al.   CIRCULATION RESEARCH

Renin-angiotensin system inhibitors in COVID-19

(2020) George Thomas   CLEVELAND CLINIC JOURNAL OF MEDICINE

Angiotensin‐converting enzyme‐2 ( ACE2 ), SARS‐CoV ‐2 and pathophysiology of coronavirus disease 2019 ( COVID ‐19)

(2020) Arno R. Bourgonje et al.   JOURNAL OF PATHOLOGY

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

(2020) Harmony R. Reynolds et al.   NEW ENGLAND JOURNAL OF MEDICINE

COVID‐19 and arterial hypertension: Hypothesis or evidence?

(2020) Marijana Tadic et al.   Journal of Clinical Hypertension

COVID-19 and Renal Diseases: An Update

(2020) Letícia Bitencourt Cota et al.   CURRENT DRUG TARGETS

Long-term consequences of COVID-19: research needs

(2020) Dana Yelin et al.   LANCET INFECTIOUS DISEASES

COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment

(2020) Anant Parasher   POSTGRADUATE MEDICAL JOURNAL

COVID-19: from an acute to chronic disease? Potential long-term health consequences

(2020) Victoria Higgins et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2

(2020) Francesca Salamanna et al.   Frontiers in Medicine

The renin‐angiotensin‐aldosterone system and its suppression

(2019) Marisa K. Ames et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Arterial stiffness as a risk factor for clinical hypertension

(2017) Michel E. Safar   Nature Reviews Cardiology

Chloroquine Suppresses the Development of Hypertension in Spontaneously Hypertensive Rats

(2016) Cameron G. McCarthy et al.   AMERICAN JOURNAL OF HYPERTENSION

Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats

(2016) Cameron G. McCarthy et al.   PHARMACOLOGICAL RESEARCH